RAYSA MORALES DEMORI to Female
This is a "connection" page, showing publications RAYSA MORALES DEMORI has written about Female.
Connection Strength
0.124
-
Assessment of B-Natriuretic Peptide Levels After Stage 1 Palliation in Hypoplastic Left Heart Syndrome Patients. Pediatr Cardiol. 2025 Oct; 46(7):1833-1841.
Score: 0.034
-
Epidemiology of Pediatric Heart Failure in the USA-a 15-Year Multi-Institutional Study. Pediatr Cardiol. 2021 Aug; 42(6):1297-1307.
Score: 0.027
-
Trend of Endurance Level Among Healthy Inner-City Children and Adolescents Over Three Decades. Pediatr Cardiol. 2017 Jan; 38(1):123-127.
Score: 0.020
-
The safety and tolerability of regadenoson in patients with end-stage renal disease: the first prospective evaluation. J Nucl Cardiol. 2013 Apr; 20(2):205-13.
Score: 0.015
-
Extracorporeal cardiopulmonary resuscitation for pediatric out-of-hospital cardiac arrest: A review of the Extracorporeal Life Support Organization Registry. Resuscitation. 2024 10; 203:110380.
Score: 0.008
-
Age and gender as predictors of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: a substudy of the ASSUAGE trial. Am J Ther. 2013 Nov-Dec; 20(6):622-9.
Score: 0.008
-
Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials. J Nucl Cardiol. 2015 Oct; 22(5):1008-18.
Score: 0.004
-
The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: a substudy of the ASSUAGE trial. J Nucl Cardiol. 2014 Jun; 21(3):496-502.
Score: 0.004
-
Attenuation of the side effect profile of regadenoson: a randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging. "The ASSUAGE trial". J Nucl Cardiol. 2012 Jun; 19(3):448-57.
Score: 0.004